Results 181 to 190 of about 279,790 (190)

Mechanisms of resistance to CAR T cell therapy

Nature Reviews Clinical Oncology, 2019
Nirali N Shah, Terry J Fry
exaly  

CAR T cell therapy for multiple myeloma

Nature Cancer, 2023
openaire   +2 more sources

Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies

Frontiers in Oncology, 2019
Jiali Cheng, Lei Zhao, Yuanyuan Zhang
exaly  

Immunotherapy-related cognitive impairment after CAR T cell therapy in mice

Cell
Anna C Geraghty, Vrunda Trivedi, Rebecca Mancusi   +2 more
exaly  

Updates on CAR T‐cell therapy in B‐cell malignancies

Immunological Reviews, 2019
Elad Jacoby, Nirali N Shah
exaly  

Frontiers in CAR-T cell therapy for autoimmune diseases

Trends in Pharmacological Sciences
Yan-Ruide Li
exaly  

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

New England Journal of Medicine
Adolfo Aleman, Oliver Van Oekelen, David T. Melnekoff, Leah Grossman, Tarek H. Mouhieddine, Agata Kurowski, Ivan Odak, Sidorela Reci, Shriya Desai, Shannon Meledathu, Malini P. Naidu, Ravi P. Shukla, Rudra P. Dutta, Katerina Kappes, Kseniya Serebryakova, Hayley Jackson, Jordan Lu, Anastasia Chatikhine, Raksha Kulkarni, Zahra Moinfar, Matthew M. Croken, Meenakshi Mehrotra, Brett Baskovich, Sampanna Rayamajhi, Shambavi Richard, Adriana C. Rossi, Christian Salib, Jane Houldsworth, Brian D. Brown, Miriam Merad, Alessandro Laganà, Patrick M. Brunner, Sundar Jagannath, Joshua D. Brody, Samir Parekh   +34 more
openaire   +2 more sources

CAR T Cell Membrane Camouflaged Nanocatalyst Augments CAR T Cell Therapy Efficacy Against Solid Tumor

Small
Peng Jiang, Haimei Li
exaly  

From concept to cure: The evolution of CAR-T cell therapy

Molecular Therapy
Kisha Patel, Mito Tariveranmoshabad, Siddhant Kadu   +2 more
exaly  

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Lancet, The
John H Baird, Yasodha Natkunam, Yi-Jiun Su   +2 more
exaly